Close Menu

tumor sequencing

The combined offering will enable customers to assess health outcomes and therapy effectiveness at the patient-anonymous level.

The Broad will partner with Dana-Farber/Harvard Cancer Center and Memorial Sloan Kettering Cancer Center on a large tumor sequencing study.

During a conference call, management discussed new commercial initiatives and investments, reimbursement progress, and its partnership with Roche.

In Science this week: measles virus nucleocapsid structure, and more.

Among other initiatives, the firms will develop new molecular and companion diagnostic tests and kits, while Roche will sell Foundation's tests outside the US.

NEW YORK (GenomeWeb News) – A study in Nature Genetics suggests alterations to two chromatin-remodeling genes — ARID1A and ARID1B — are linked to particularly poor neuroblastoma outcomes.

NEW YORK (GenomeWeb News) – A pair of studies in the early, online version of Nature Genetics are highlighting the types of genetic mutations that underlie the liver cancer hepatocellular carcinoma, including forms of the disease related to hepatitis B and hepatitis C virus infection.

NEW YORK (GenomeWeb News) – The St. Jude Children's Research Hospital-Washington University Pediatric Cancer Genome Project announced today that it is releasing genome sequence data for hundreds of matched tumor-normal samples assessed through the collaboration.

Illumina will provide a range of services, starting with whole genome sequencing, to support the International Cancer Genome Consortium.

Pages

NPR says the explosion and fire earlier this week at a Russian lab that stores dangerous pathogens revives the question of whether such samples should be kept.

According to Wired, Nebula Genomics is providing a way for people to get their genomes sequenced anonymously.

A 26-year-old woman tells Cosmopolitan about learning her APOE status at a young age.

In Science journals this week: a functional genomic screen uncovers drug combination that increases KRAS inhibitor efficacy in aggressive lung cancer, and more.